{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:34:28Z","timestamp":1792550068867,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:00:00Z","timestamp":1565827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:00:00Z","timestamp":1565827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Invasive pulmonary aspergillosis (IPA) is an important cause of morbidity\/mortality in critically ill patients with endstage liver disease. Therefore, aim of this study is to predict the prevalence and outcome of IPA in critically ill patients with underlying liver cirrhosis and evaluation of the necessity Glactomannan (GM) screening in serum and bronchoalveolar lavage (BAL) in this cohort. In total 12 out of 84 patients (14%) had probable IPA. The mean optical density index (ODI) bronchoalveolar lavage (BAL) GM index was 3.6\u2009\u00b1\u20091.5 (Range: 1.7\u20135.7). An overall sensitivity of 90% (95% CI 86\u201396%) and specificity of 85% (95% CI 81\u201388%) was found for the BAL GM in IPA. Acute Physiology And Chronic Health Evaluation (APACHE II), sequential organ failure assessment (SOFA) as well the model of endstage liver disease (MELD) score were significantly higher in the probable IPA group as compared to the No IPA group (26 versus 21, p\u2009&lt;\u20090.001 and 14 versus 10, p\u2009&lt;\u20090.044). Length of intensive care unit (ICU) stay was significantly longer in probable IPA patients (16 versus 10 days, p\u2009&lt;\u20090.027) and mortality rate was significantly higher in probable IPA patients (100% versus 65%, p\u2009&lt;\u20090.001) as compared to No IPA patients. APACHE II and MELD score were independently associated with higher mortality rate using multivariate logistic regression (p\u2009=\u20090.025 and p\u2009=\u20090.034). In conclusion, IPA has a relevant impact on outcome. Screening for IPA is indicated, easy to perform and a necessity to improve outcome.<\/jats:p>","DOI":"10.1038\/s41598-019-48183-4","type":"journal-article","created":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T10:02:31Z","timestamp":1565863351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: an observational study"],"prefix":"10.1038","volume":"9","author":[{"given":"Tobias","family":"Lahmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-8017","authenticated-orcid":false,"given":"Sebastian","family":"Rasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo Batres","family":"Baires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,15]]},"reference":[{"issue":"5","key":"48183_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","volume":"65","author":"William J. Steinbach","year":"2012","unstructured":"Steinbach, W. J. et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect. Nov 65(5), 453\u201364 (2012).","journal-title":"Journal of Infection"},{"key":"48183_CR2","doi-asserted-by":"crossref","unstructured":"Bassetti, M., Peghin, M. & Vena, A. Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review. Infect Dis Ther. Mar; 7(1), 17\u201327 (2018).","DOI":"10.1007\/s40121-017-0183-9"},{"issue":"1-2","key":"48183_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11046-014-9825-6","volume":"179","author":"Tobias Lahmer","year":"2014","unstructured":"Lahmer, T. et al. Fungal \u201ccolonisation\u201d is associated with increased mortality in medical intensive care unit patients with liver cirrhosis. Mycopathologia. Feb; 179(1\u20132), 63\u201371 (2015).","journal-title":"Mycopathologia"},{"issue":"5","key":"48183_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2143\/ACB.3408","volume":"68","author":"S Jeurissen","year":"2013","unstructured":"Jeurissen, S. et al. Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years. Acta Clin Belg. Sep-Oct; 68(5), 368\u201375 (2013).","journal-title":"Acta Clinica Belgica"},{"key":"48183_CR5","doi-asserted-by":"crossref","unstructured":"Vaezi A. et al. Frequency and Geographic Distribution of CARD9 Mutations in Patients With Severe Fungal Infections. Front Microbiol. Oct 12; 9, 2434 (2018).","DOI":"10.3389\/fmicb.2018.02434"},{"issue":"6","key":"48183_CR6","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","volume":"61","author":"Agust\u00edn Albillos","year":"2014","unstructured":"Albillos, A., Lario, M., \u00c1lvarez-Mon, M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. Dec; 61(6), 1385\u201396 (2014).","journal-title":"Journal of Hepatology"},{"key":"48183_CR7","doi-asserted-by":"crossref","unstructured":"Gomez, F., Ruiz, P. & Schreiber, A. D. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med. Oct 27; 331(17), 1122\u20138 (1994).","DOI":"10.1056\/NEJM199410273311704"},{"issue":"2","key":"48183_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1086\/315742","volume":"182","author":"C Fiuza","year":"2000","unstructured":"Fiuza, C., Salcedo, M., Clemente, G. & Tellado, J. M. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis. Aug 182(2), 526\u201333 (2000).","journal-title":"J Infect Dis. Aug"},{"key":"48183_CR9","doi-asserted-by":"crossref","unstructured":"Bonnel, A. R., Bunchorntavakul, C. & Reddy, K. R. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. Sep; 9(9), 727\u201338 (2011).","DOI":"10.1016\/j.cgh.2011.02.031"},{"issue":"4","key":"48183_CR10","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jhep.2010.12.039","volume":"55","author":"Nicolas Coant","year":"2011","unstructured":"Coant, N. et al. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis. J Hepatol. Oct; 55(4), 784\u201393 (2011).","journal-title":"Journal of Hepatology"},{"issue":"3-4","key":"48183_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11046-014-9740-x","volume":"177","author":"Tobias Lahmer","year":"2014","unstructured":"Lahmer, T. et al. Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis. Mycopathologia Apr; 177(3\u20134), 193\u20137 (2014).","journal-title":"Mycopathologia"},{"issue":"2","key":"48183_CR12","first-page":"152","volume":"30","author":"E Karakike","year":"2017","unstructured":"Karakike, E., Moreno, C. & Gustot, T. Infections in severe alcoholic hepatitis. Ann Gastroenterol 30(2), 152\u2013160 (2017).","journal-title":"Ann Gastroenterol"},{"key":"48183_CR13","doi-asserted-by":"crossref","unstructured":"De Pauw, B. et al. European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. Jun 15; 46(12), 1813\u201321 (2008).","DOI":"10.1086\/588660"},{"issue":"8","key":"48183_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/mmy\/myx011","volume":"55","author":"Juergen Prattes","year":"2017","unstructured":"Prattes, J. et al. Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study. Med Mycol. Nov 1; 55(8), 803\u2013812 (2017).","journal-title":"Medical Mycology"},{"key":"48183_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/518852","volume":"45","author":"W Meersseman","year":"2007","unstructured":"Meersseman, W. et al. Invasive aspergillosis in the intensive care unit. Clin Infect Dis. 45, 205\u2013216 (2007).","journal-title":"Clin Infect Dis."},{"issue":"8","key":"48183_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M., Deutschman, C. S. & Seymour, C. W. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8), 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"48183_CR17","doi-asserted-by":"crossref","unstructured":"Ullmann, A. J. et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect May; 24 (Suppl 1), e1\u2013e38 (2018).","DOI":"10.1016\/j.cmi.2018.01.002"},{"key":"48183_CR18","doi-asserted-by":"crossref","unstructured":"Patterson, T. F. et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis Aug 15; 63(4), e1\u2013e60 (2016).","DOI":"10.1093\/cid\/ciw326"},{"key":"48183_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","volume":"5","author":"WW Hope","year":"2005","unstructured":"Hope, W. W., Walsh, T. J. & Denning, D. W. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5, 609\u2013622 (2005).","journal-title":"Lancet Infect Dis"},{"key":"48183_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"Meersseman, W. et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177, 27\u201334 (2008).","journal-title":"Am J Respir Crit Care Med"},{"key":"48183_CR21","doi-asserted-by":"publisher","first-page":"575e9","DOI":"10.1080\/13693780801978968","volume":"46","author":"J Guinea","year":"2008","unstructured":"Guinea, J. et al. Value of a single galactomannan determination (platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol 46, 575e9 (2008).","journal-title":"Med Mycol"},{"key":"48183_CR22","doi-asserted-by":"publisher","first-page":"e43347","DOI":"10.1371\/journal.pone.0043347","volume":"7","author":"M Zou","year":"2012","unstructured":"Zou, M. et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One 7, e43347 (2012).","journal-title":"PLoS One"},{"issue":"6","key":"48183_CR23","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1128\/JCM.00467-14","volume":"52","author":"M. Hoenigl","year":"2014","unstructured":"Hoenigl, M. et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol Jun; 52(6), 2039\u201345 (2014).","journal-title":"Journal of Clinical Microbiology"},{"issue":"3","key":"48183_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.2016.152900","volume":"102","author":"Frederic Tissot","year":"2016","unstructured":"Tissot, F. et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica Mar; 102(3), 433\u2013444 (2017).","journal-title":"Haematologica"},{"key":"48183_CR25","doi-asserted-by":"publisher","first-page":"17e25","DOI":"10.1086\/375219","volume":"37","author":"PK Linden","year":"2003","unstructured":"Linden, P. K., Coley, K., Fontes, P., Fung, J. J. & Kusne, S. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. Clin Infect Dis 37, 17e25 (2003).","journal-title":"Clin Infect Dis"},{"key":"48183_CR26","doi-asserted-by":"crossref","unstructured":"Falcone, M., Massetti, A. P., Russo, A., Vullo, V. & Venditti, M. Invasive aspergillosis in patients with liver disease. Med Mycol May; 49(4), 406\u201313 (2011).","DOI":"10.3109\/13693786.2010.535030"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48183-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48183-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48183-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:41:29Z","timestamp":1671280889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48183-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48183"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48183-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,15]]},"assertion":[{"value":"1 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11919"}}